Your browser doesn't support javascript.
loading
Cytokine Profile in Sweet's Syndrome under the Treatment of Pulmonary Toxoplasmosis Complicated with Myelodysplastic Syndrome.
Matsuzawa, Yukimasa; Adachi, Eisuke; Takahashi, Atsuko; Sato, Hidenori; Lim, Lay Ahyoung; Komatsu, Tsunehiko; Koibuchi, Tomohiko; Nagamura-Inoue, Tokiko; Tojo, Arinobu; Nagayama, Hitomi; Yotsuyanagi, Hiroshi.
Afiliação
  • Matsuzawa Y; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
  • Adachi E; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
  • Takahashi A; Department of Cell Processing and Transfusion, The Institute of Medical Science, The University of Tokyo, Japan.
  • Sato H; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
  • Lim LA; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
  • Komatsu T; Department of Hematology, Joban Hospital of Tokiwakai Group, Japan.
  • Koibuchi T; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
  • Nagamura-Inoue T; Department of Cell Processing and Transfusion, The Institute of Medical Science, The University of Tokyo, Japan.
  • Tojo A; Department of Hematology/Oncology, Research Hospital The Institute of Medical Science, The University of Tokyo, Japan.
  • Nagayama H; Department of Hematology, Teikyo University Chiba Medical Center, Japan.
  • Yotsuyanagi H; Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Japan.
Intern Med ; 58(14): 2079-2083, 2019 Jul 15.
Article em En | MEDLINE | ID: mdl-30918190
ABSTRACT
We herein describe a case of Sweet's syndrome (SS) in a patient being treated for pulmonary toxoplasmosis complicated with myelodysplastic syndrome (MDS). The patient's SS developed after the pulmonary toxoplasmosis improved following treatment. We searched his cytokine profiles comprehensively using a bead-based immunoassay. The results showed no elevation of interleukin (IL)-2, interferon (IFN)-γ or IL-17A, and IL-6 was only observed to have increased at the onset of SS, suggesting that the pulmonary toxoplasmosis had been well controlled and that chronic inflammation may have been the cause of SS. Pulmonary toxoplasmosis is an extremely rare occurrence. The cytokine profile can help to clarify the pathological condition of SS and MDS complicated with severely invasive infectious diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Toxoplasmose / Citocinas / Síndrome de Sweet / Antiprotozoários Limite: Aged / Female / Humans Idioma: En Revista: Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Toxoplasmose / Citocinas / Síndrome de Sweet / Antiprotozoários Limite: Aged / Female / Humans Idioma: En Revista: Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão